World Hepatitis Day: Global Action Needed to Combat Liver Disease

World Hepatitis Day, observed annually on July 28, serves as a crucial global platform to raise awareness about viral hepatitis and to galvanize action towards its elimination as a public health threat. This day holds particular significance as it marks the birthday of Nobel Prize-winning scientist Dr. Baruch Blumberg, who made groundbreaking contributions by discovering the hepatitis B virus (HBV) and subsequently developing a diagnostic test and vaccine for it. The significance of World Hepatitis Day extends beyond a mere commemoration. It is a critical juncture for stepping up national and international efforts to combat viral hepatitis, encouraging engagement from individuals, partners, and the public. The World Health Organization (WHO) has set an ambitious goal to eliminate viral hepatitis as a public health threat by 2030. This objective involves a 90% reduction in new infections and a 65% reduction in mortality from hepatitis B and C by 2030. Hepatitis, an inflammation of the liver, is primarily caused by five types of viruses: A, B, C, D, and E. While Hepatitis A and E are typically acute and self-limiting, Hepatitis B, C, and D can lead to chronic infections, posing significant risks of liver fibrosis, cirrhosis, and liver cancer. Viral hepatitis is a major global health concern, causing an estimated 1.3 million deaths annually, a figure that tragically exceeds deaths from HIV/AIDS and malaria combined. In 2022, approximately 304 million people were living with chronic hepatitis B and C globally. Despite the availability of vaccines for Hepatitis B and effective treatments for Hepatitis C, the global goal of elimination remains elusive. A significant gap lies in the low coverage of testing and treatment. Many individuals, particularly those with Hepatitis B and C, remain unaware of their infection due to its often asymptomatic nature, allowing the disease to progress silently. Globally, only 45% of infants received the hepatitis B vaccine within 24 hours of birth in 2022. Furthermore, only 4.5% of people living with chronic hepatitis B and C received treatment in 2022. India faces a substantial burden of viral hepatitis. It is estimated that around 40 million people in India are chronically infected with Hepatitis B, and 6 to 12 million with Hepatitis C. India accounts for a significant portion of the global disease load, contributing to approximately 69% of global Hepatitis B deaths and 58% of global Hepatitis C deaths. To address this, India launched the National Viral Hepatitis Control Programme (NVHCP) in 2018, aiming to provide free diagnosis and treatment for Hepatitis B and C, and increase vaccination access. The program is integrated with various national health initiatives to enhance prevention and control. The theme for World Hepatitis Day 2024 is "It's time for action". This theme underscores the urgent need for collaborative efforts, increased access to diagnosis and treatment, and greater public awareness to accelerate progress towards the 2030 elimination goals. The challenges are immense, but with concerted action, the elimination of viral hepatitis is considered achievable. In summary, World Hepatitis Day on July 28 is a vital reminder of the global impact of viral hepatitis and the urgent need for increased action. While significant progress has been made in understanding and managing hepatitis, critical gaps in testing and treatment coverage hinder the achievement of the WHO's 2030 elimination goals. Continued global collaboration, public awareness campaigns, and strengthened healthcare systems are essential to overcome these challenges and create a hepatitis-free future.

Frequently Asked Questions

Read Full Story on Quick Digest